May 31, 2013
Nouriast Tablets 20 mg Kyowa Hakko Kirin launched on May 30 its novel Parkinson’s disease treatment Nouriast Tablets 20 mg (istradefylline). The drug is the world’s first antiparkinson agent of a first-in-class adenosine A 2A receptor antagonist. The NHI price...read more